Evidence map›Paper›PMID 40522962›Full record

ArticlePloS one2025

Antimicrobial resistance and molecular detection of extended-spectrum ß-lactamase (ESBL)-producing Escherichia coli in municipal wastewater in Marrakech.

Oumaima El Garraoui, Amal Loqman, Fatima-Ezahra Amouat, Said Hasnaoui, Nabila Soraa, Souad Loqman

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oumaima El GarraouiLaboratoire de Lutte Contre les Maladies Infectieuses, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Morocco.
Amal LoqmanLaboratoire de Lutte Contre les Maladies Infectieuses, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Morocco.
Fatima-Ezahra AmouatLaboratoire de Lutte Contre les Maladies Infectieuses, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Morocco.
Said HasnaouiLaboratoire de Lutte Contre les Maladies Infectieuses, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Morocco.
Nabila SoraaLaboratoire de Lutte Contre les Maladies Infectieuses, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Morocco.
Souad LoqmanLaboratoire de Lutte Contre les Maladies Infectieuses, Faculté de Médecine et de Pharmacie, Université Cadi Ayyad, Marrakech, Morocco.ORCID 0000-0003-0671-9107

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) poses a major threat to public health. However, its environmental dissemination, especially through wastewater, remains insufficiently addressed. This paper examines the presence of ESBL-EC in composite influent and effluent samples from Marrakech's wastewater treatment plant. Samples were screened on selective agar and isolated strains were identified by MALDI Biotyper® Sirius System. The sensitivity of bacteria to antibiotics was determined by disk diffusion method and phenotypic tests were conducted to detect ESBL production. Molecular identification was characterized by PCR and DNA sequencing. From a total of 72 wastewater samples, 364 resistant Enterobacteriaceae isolates were recovered, of which 134 were confirmed as ESBL-EC, with 78.35% exhibiting multidrug resistance (MDR) phenotypes. The blaCTX-M gene was the most prevalent among isolates obtained from influent samples, followed by blaTEM at 81.25% and blaSHV at 16.67%. Although biological treatment reduced the number of ESBL-EC isolates harboring resistance genes, a significant proportion remained detectable in the final effluent, even after UV disinfection, highlighting the limited efficacy of standard treatment processes in eliminating them. These findings underscore the urgent need to enhance wastewater treatment strategies. Implementing advanced technologies, such as membrane filtration or ozonation, combined with routine monitoring, is critical to reduce the environmental release of resistant bacteria and mitigate their public health risks.

Indexed as

beta-LactamasesDrug Resistance, BacterialEscherichia coliWastewaterAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsWater MicrobiologyAnti-Bacterial Agentsbeta-LactamasesWastewater

Identifiers

PMID40522962
PMCPMC12169590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.